Guggenheim Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $249K | Sell |
|
|||||
|
2023
Q1 | $473K | Buy |
|
|||||
|
2022
Q4 | $467K | Buy |
|
|||||
|
2022
Q3 | $416K | Sell |
|
|||||
|
2022
Q2 | $873K | Buy |
|
|||||
|
2022
Q1 | $877K | Buy |
|
|||||
|
2021
Q4 | $832K | Sell |
|
|||||
|
2021
Q3 | $1.34M | Buy |
|
|||||
|
2021
Q2 | $722K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $207K | Sell |
|
|||||
|
2020
Q1 | $5.72M | Sell |
|
|||||
|
2019
Q4 | $7.52M | Buy |
|
|||||
|
2019
Q3 | $6.89M | Sell |
|
|||||
|
2019
Q2 | $6.81M | Sell |
|
|||||
|
2019
Q1 | $6.18M | Sell |
|
|||||
|
2018
Q4 | $5.02M | Buy |
|
|||||
|
2018
Q3 | $6.06M | Sell |
|
|||||
|
2018
Q2 | $8.81M | Sell |
|
|||||
|
2018
Q1 | $10M | Buy |
|
|||||
|
2017
Q4 | $7.28M | Sell |
|
|||||
|
2017
Q3 | $8.45M | Buy |
|
|||||
|
2017
Q2 | $10.4M | Buy |
|
|||||
|
2017
Q1 | $3.14M | Sell |
|
|||||
|
2016
Q4 | $3.12M | Sell |
|
|||||
|
2016
Q3 | $5.26M | Buy |
|
|||||
|
2016
Q2 | $1.62M | Buy |
|
|||||
|
2016
Q1 | $1.49M | Buy |
|
|||||
|
2015
Q4 | $1.87M | Sell |
|
|||||
|
2015
Q3 | $1.62M | Buy |
|